The U.S. could authorize the firing of Pfizer COVID-19 for children ages 5 to 11 in October, according to sources
/cloudfront-us-east-2.images.arcpublishing.com/reuters/WZT3C5BDKRM7VBXUNNEG27LKHA.jpg "An Indian study found a large drop in COVID antibodies in the four months following vaccination")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/LOOZGBF6XRKNNIRTMNXOOHI3GM.jpg "England will offer the COVID vaccine to all young people aged 12 to 15")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BD5K2CF4GRPRHETPBE3BAELBIU.jpg "COVID-19 vaccine boosters are not much needed, according to leading FDA and WHO scientists")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BGA77H52OVP6RPKR57A6ZVWABA.jpg "The Australian state of NSW says the rate of coronavirus vaccination is slowing")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3M6EZH7B3FKAZFLYT5GKEEHHZI.jpg "Britain is launching the world’s largest blood test for 50 cancers")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PE5M37V6IBJITAUYLO3QKL4XMU.jpg "New Zealand buys 500,000 COVID-19 vaccines as the cluster grows")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/5W5SVMQUMFMDVNYOKU6PM55YLY.jpg "Australia buys additional doses of 1 million COVID-19 vaccines from Moderna")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/JHQ5KDUZBBMQPFYHJM7VZ2EEME.jpg "British Prime Minister Johnson will address parliament for COVID-19, according to a BBC reporter")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/GGF544HPPRK2VLHWSNEWYFYVKQ.jpg "The U.S. could authorize the firing of Pfizer COVID-19 for children ages 5 to 11 in October, according to sources")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/LGDRTWA5SBP2VGI7T7DSJDCVD4.jpg "Novavax expects to make at least 2 trillion doses of COVID-19 vaccine available in 2022")